Gut microbiota and IBD (Q28294695)

https://doi.org/10.1016%2FS0399-8320%2810%2970020-8

25 March 2017

author name string

P Seksik

series ordinal

1

0 references

P. Seksik

series ordinal

1

1 reference

https://doi.org/10.1016%2FS0399-8320%2810%2970020-8

25 March 2017

publication date

September 2010

1 reference

https://doi.org/10.1016%2FS0399-8320%2810%2970020-8

Gastroenterologie Clinique et Biologique

25 March 2017

published in

1 reference

https://doi.org/10.1016%2FS0399-8320%2810%2970020-8

25 March 2017

volume

34 Suppl 1

0 references

34

1 reference

https://doi.org/10.1016%2FS0399-8320%2810%2970020-8

25 March 2017

page(s)

S44-51

0 references

S44-S51

1 reference

https://doi.org/10.1016%2FS0399-8320%2810%2970020-8

Experimental models of inflammatory bowel disease

25 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Mucosal flora in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Role of the faecal stream in the maintenance of Crohn's colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Colonic bacteria express an ulcerative colitis pANCA-related protein epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Specificities of the fecal microbiota in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Molecular inventory of faecal microflora in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2810%2970020-8

7 January 2021

10.1016/S0399-8320(10)70020-8

Identifiers

DOI

1 reference

https://doi.org/10.1016%2FS0399-8320%2810%2970020-8